Cooper Current Ratio 2010-2022 | COO

Current and historical current ratio for Cooper (COO) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Cooper current ratio for the three months ending April 30, 2022 was 1.06.
Cooper Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-04-30 $1.74B $1.65B 1.05
2022-01-31 $1.70B $1.66B 1.02
2021-10-31 $1.47B $0.73B 2.00
2021-07-31 $1.48B $1.06B 1.39
2021-04-30 $1.32B $0.99B 1.33
2021-01-31 $1.30B $0.96B 1.35
2020-10-31 $1.27B $1.00B 1.27
2020-07-31 $1.32B $1.13B 1.17
2020-04-30 $1.17B $1.03B 1.14
2020-01-31 $1.15B $1.07B 1.08
2019-10-31 $1.16B $1.11B 1.05
2019-07-31 $1.15B $0.89B 1.29
2019-04-30 $1.14B $0.94B 1.21
2019-01-31 $1.19B $0.94B 1.27
2018-10-31 $1.09B $0.54B 2.03
2018-07-31 $1.19B $0.46B 2.58
2018-04-30 $1.27B $0.46B 2.76
2018-01-31 $1.18B $0.42B 2.83
2017-10-31 $0.95B $0.40B 2.41
2017-07-31 $0.93B $0.37B 2.51
2017-04-30 $0.96B $0.34B 2.79
2017-01-31 $0.88B $0.52B 1.71
2016-10-31 $0.94B $0.54B 1.73
2016-07-31 $0.93B $0.32B 2.90
2016-04-30 $0.92B $0.32B 2.84
2016-01-31 $0.85B $0.35B 2.43
2015-10-31 $0.84B $0.57B 1.48
2015-07-31 $0.82B $0.53B 1.54
2015-04-30 $0.80B $0.54B 1.49
2015-01-31 $0.79B $0.38B 2.06
2014-10-31 $0.79B $0.44B 1.79
2014-07-31 $0.90B $0.30B 3.01
2014-04-30 $0.77B $0.27B 2.89
2014-01-31 $0.70B $0.27B 2.61
2013-10-31 $0.75B $0.32B 2.33
2013-07-31 $0.71B $0.25B 2.83
2013-04-30 $0.68B $0.23B 2.95
2013-01-31 $0.68B $0.23B 3.01
2012-10-31 $0.66B $0.26B 2.51
2012-07-31 $0.63B $0.23B 2.71
2012-04-30 $0.58B $0.23B 2.53
2012-01-31 $0.56B $0.21B 2.69
2011-10-31 $0.54B $0.27B 2.02
2011-07-31 $0.54B $0.24B 2.29
2011-04-30 $0.54B $0.21B 2.61
2011-01-31 $0.50B $0.19B 2.71
2010-10-31 $0.49B $0.20B 2.46
2010-07-31 $0.49B $0.22B 2.19
2010-04-30 $0.49B $0.21B 2.37
2010-01-31 $0.50B $0.18B 2.78
2009-10-31 $0.50B $0.18B 2.87
2009-07-31 $0.52B $0.21B 2.44
2009-04-30 $0.53B $0.21B 2.47
2009-01-31 $0.54B $0.25B 2.11
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.496B $2.923B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $69.707B 20.13
McKesson (MCK) United States $46.168B 13.57
AmerisourceBergen (ABC) United States $29.993B 13.84
West Pharmaceutical Services (WST) United States $21.960B 33.46
Laboratory Of America Holdings (LH) United States $21.873B 9.14
Cardinal Health (CAH) United States $14.662B 11.26
CONMED (CNMD) United States $2.878B 29.72
Invacare (IVC) United States $0.053B 0.00